Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 75Neoplasms 15Neoplasm Metastasis 9Advanced Breast Cancer 5Neoplasms by Site 3Breast Diseases 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Patient Compliance 2Ovarian Neoplasms 2Endometrial Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Skin Diseases 1Recurrence 1Quality of Life 1Osteoporosis 1Multiple Endocrine Neoplasia Type 1 1Low Grade Serous Ovarian Cancer 1Lethal Congenital Contracture Syndrome 2 1Joint Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Cancer Metastatic 1Bone Diseases, Metabolic 1Bone Density 1Arthralgia 1Advanced Metastatic Breast Cancer 1

Interventions

canakinumab 1Testosterone 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Arthralgia × Anastrozole × Clear all
NCT00660244 2012-06-06

Breast Cancer Tumor Care Observational Programme

AstraZeneca

Completed
150 enrolled

Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡